Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic OutcomesHidenori Ando, Tatsuhiro Ishida|Biological and Pharmaceutical Bulletin|2021Cited by 17
Potential Efficacy of Proteasome Inhibitor, Delanzomib, for the Treatment of Renal FibrosisAyano Sawa-Aihara, Tatsuhiro Ishida|Biological and Pharmaceutical Bulletin|2023Cited by 3